Meet the expert...
Associate Scientist, Upstream Process Development at KBI Biopharma
Chia-Yun (Dora) Wu joined KBI Biopharma’s Upstream Process Development in 2018. Her experience includes clinical and commercial process development for Fc fusion protein, bi-specific antibodies, and monoclonal antibodies. Dedicated to innovation in cell culture process, Dora’s focuses include perfusion and high-density bioprocess. Prior to KBI, Dora worked at Altor Bioscience in Miramar, Florida for 2 years as an associate scientist. Dora received her MS degree in Biotechnology from Northwestern University.